The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China (mainland).
Department of Otorhinolaryngology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China (mainland).
Med Sci Monit. 2020 Mar 1;26:e920872. doi: 10.12659/MSM.920872.
FUZI (Aconiti Lateralis Radix Praeparata) is a traditional Chinese medicine herb used extensively for nourishing yang (regarded as the positive, male universal force), which is critical in treatment of allergic rhinitis. In this paper, FUZI was explored based on network pharmacology. The active components of FUZI were screened out, its protein targets were assessed, and the protein interaction network map was built with the differential protein of allergic rhinitis, as an attempt to determine the critical targets of FUZI for treating allergic rhinitis. Subsequently, DAVID was employed to explore the biological function and pathway enrichment to determine the biological pathway of FUZI for treating allergic rhinitis. As suggested by the results, FUZI is likely to affect the inhibition of inflammation and the regulation of immunity, probably reducing the incidence of allergic rhinitis, or alleviating nasal discomfort attributed to allergic inflammation. The targets and pathways of FUZI for treating allergic rhinitis assessed by network pharmacology provided a direction for our subsequent studies and may be a novel therapeutic target.
附子(制乌头)是一种广泛用于滋补阳(被认为是阳性、男性普遍力量)的中药,在治疗过敏性鼻炎方面至关重要。本文基于网络药理学对附子进行了探讨。筛选出附子的活性成分,评估其蛋白质靶标,并构建过敏性鼻炎差异蛋白的蛋白质相互作用网络图,试图确定附子治疗过敏性鼻炎的关键靶标。随后,利用 DAVID 探讨生物功能和途径富集,确定附子治疗过敏性鼻炎的生物学途径。结果表明,附子可能影响炎症的抑制和免疫的调节,可能降低过敏性鼻炎的发病率,或缓解过敏性炎症引起的鼻部不适。网络药理学评估的附子治疗过敏性鼻炎的靶点和途径为我们的后续研究提供了方向,可能成为新的治疗靶点。